Patents Assigned to RESUSCITEC GMBH
  • Patent number: 11536631
    Abstract: The invention relates to a fluid analysis module that comprises for blood analysis: a module housing with a fluid inlet port; at least one fluid sensor that is integrated within the module housing and comprises a sensor surface that is able to make a fluidic connection with the fluid inlet port; a chamber integrated within the module housing. The chamber can be brought into a fluidic connection with the sensor surface of the at least one fluid sensor.
    Type: Grant
    Filed: July 4, 2018
    Date of Patent: December 27, 2022
    Assignee: RESUSCITEC GMBH
    Inventors: Christoph Benk, Juergen Grudke, Rainer Feldbruegge, Michael Borchardt
  • Patent number: 11351303
    Abstract: The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: June 7, 2022
    Assignee: ResuSciTec GmbH
    Inventor: Friedhelm Beyersdorf
  • Patent number: 11185574
    Abstract: The present invention relates to a protective solution for preventing or reducing reperfusion injury of the brain which contains magnesium ions and which has an osmolality of 350 to 600 mOsm/L, a pH value of 6.8 to 7.8 and albumin in an amount of 1 to 20% by weight.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: November 30, 2021
    Assignee: ResuSciTec GmbH
    Inventors: Christoph Benk, Friedhelm Beyersdorf, Georg Trummer
  • Patent number: 10695407
    Abstract: The present invention relates to a protective solution for preventing or reducing reperfusion injury of the brain which contains magnesium ions and which has an osmolality of 350 to 600 mOsm/L, a pH value of 6.8 to 7.8 and albumin in an amount of 1 to 20% by weight.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: June 30, 2020
    Assignee: ResuSciTec GmbH
    Inventors: Christoph Benk, Friedhelm Beyersdorf, Georg Trummer
  • Patent number: 10603426
    Abstract: The invention relates to a container in the form of a bag having a flexible bag wall at least in a region, in which a first and a second hollow channel section, pass through the bag wall in a fluid-tight manner, wherein the hollow channel sections respectively have an open channel end that is located within the container for connecting the open channel ends to one another in a separable and fluid-tight manner.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: March 31, 2020
    Assignee: RESUSCITEC GMBH
    Inventors: Christoph Benk, Jürgen Grudke, Joel Louoba
  • Patent number: 10314973
    Abstract: The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: June 11, 2019
    Assignee: ResuSciTec GmbH
    Inventor: Friedhelm Beyersdorf
  • Patent number: 10086139
    Abstract: The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: October 2, 2018
    Assignee: ResuSciTec GmbH
    Inventor: Friedhelm Beyersdorf
  • Patent number: 9402952
    Abstract: The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).
    Type: Grant
    Filed: October 11, 2010
    Date of Patent: August 2, 2016
    Assignee: RESUSCITEC GMBH
    Inventor: Friedhelm Beyersdorf
  • Patent number: D900320
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: October 27, 2020
    Assignee: RESUSCITEC GMBH
    Inventors: Joachim Wilke, Christoph Benk